Listed Patents Clause Samples
Listed Patents. The issued patents and pending patent applications listed on Schedule 4.11
(a) Listed Patents Schedule 4.11(a) specifies (x) with respect to each Listed Patent that is an issued patent, (i) the jurisdiction in which such Listed Patent has issued as a patent and (ii) the patent number of such Listed Patent and (y) with respect to each Listed Patent that is a pending patent application, (i) the jurisdiction in which such Listed Patent is pending and (ii) the patent application number of such Listed Patent. In addition, Schedule 4.11(a) specifies with respect to each Listed Patent (A) whether such Listed Patent is a Collaboration Patent or an AnaptysBio Patent and (B) each record owner of such Listed Patent. To the Knowledge of Seller, the Listed Patents constitute all issued patents and pending patent applications within the AnaptysBio Patents and Collaboration Patents under the License Agreement that pertain to the PD-1 Discovery Program and/or Dostarlimab.
Listed Patents. As of the Execution Date and the Effective Date, the Listed Patents are the only Licensed Patents and are the only Patents Controlled by OncoC4 or any Affiliate of OncoC4 that Claim a Licensed Compound or Licensed Product. As of the Execution Date and the Effective Date, OncoC4 Controls the Listed Patents with respect to Licensed Compound and Licensed Product. The issued Listed Patents are to the best of OncoC4’s knowledge valid and enforceable; the pending Listed Patents have been prosecuted in good faith and in accordance with all legal duties of the applicant imposed by patent Laws.
Listed Patents. The issued patents and pending patent applications listed on Schedule 4.12(a) are referred to in this Agreement as the “Listed Patents.” Schedule 4.12(a) specifies (x) with respect to each Listed Patent that is an issued patent, (i) the jurisdiction in which such Listed Patent has issued as a patent and (ii) the patent number of such Listed Patent and (y) with respect to each Listed Patent that is a pending patent application, (i) the jurisdiction in which such Listed Patent is pending and (ii) the patent application number of such Listed Patent.
Listed Patents. [ * ] [ * ] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Act of 1934, as amended. This Global Policy describes what is required to meet our commitment to operate ethically and with integrity in our business and personal interactions and activities. This Policy applies to all Employees. The Company is committed to acting responsibly and in compliance with the requirements of the UK Bribery Act, Foreign Corrupt Practices Act and other relevant laws, regulations and adopted industry codes
Listed Patents. The issued patents and pending patent applications listed on Part 4.11(a) of the Disclosure Document are referred to in this Agreement as the “Listed Patents”. Part 4.11(a) of the Disclosure Document specifies (i) with respect to each Listed Patent that is an issued patent, (A) the jurisdiction in which such Listed Patent has issued as a patent and (B) the patent number of such Listed Patent, and (ii) with respect to each Listed Patent that is a pending patent application, (A) the jurisdiction in which such Listed Patent is pending and (B) the patent application number of such Listed Patent. [***].